搜尋結果
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 4 日前Eli Lilly became the most valuable health-care company in the world on the back of its ...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 5 日前The panel concluded that the therapeutic is effective in treating the memory-robbing condition ...